Graphs show data for CD4+ T cells (B), CD8+ T cells (C) and CD19+ B cells (D). 2OA manifest autoimmune cholangitis, typical mitochondrial autoantibodies, increased
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
Graphs show data for CD4+ T cells (B), CD8+ T cells (C) and CD19+ B cells (D). 2OA manifest autoimmune cholangitis, typical mitochondrial autoantibodies, increased